1 - 5 out of 5Page size: 10
  1. 2021

  2. Novel approach to the delivery into the cells and light-activation of the guide RNA for the genome editing CRISPR/Cas9 system

    Яковлев, А., Ахметова, Е., Данилин, Н. А., Семиколенова, О. А., Вохтанцев, И. П., Ким, Д. В., Жарков, Д. О., Веньяминова, А. Г. & Новопашина, Д. С., Jul 2021, p. 122. 1 p.

    Research output: Contribution to conference › Abstract › peer-review

  3. The prospective antibacterial conjugates of modified oligonucleotides

    Danilin, N., Novopashina, D., Matveyev, A., Bardasheva, A., Tikunova, N., Kupryushkin, M., Pyshnyi, D. & Venyaminova, A., Jul 2021, In: FEBS Open Bio. 11, p. 307-307 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  4. Conjugates of RNase P-Guiding Oligonucleotides with Oligo(N-Methylpyrrole) as Prospective Antibacterial Agents

    Danilin, N. A., Matveev, A. L., Tikunova, N. V., Venyaminova, A. G. & Novopashina, D. S., Mar 2021, In: Russian Journal of Bioorganic Chemistry. 47, 2, p. 469-477 9 p.

    Research output: Contribution to journal › Article › peer-review

  5. 2019

  6. RNase P-Guiding Peptide Conjugates of Oligo(2'-O-methylribonucleotides) as Prospective Antibacterial Agents

    Danilin, N. A., Koroleva, L. S., Novopashina, D. S. & Venyaminova, A. G., 1 Nov 2019, In: Russian Journal of Bioorganic Chemistry. 45, 6, p. 825-832 8 p.

    Research output: Contribution to journal › Article › peer-review

  7. Novel peptide conjugates of modified oligonucleotides for inhibition of bacterial RNase P

    Novopashina, D., Vorobyeva, M., Nazarov, A., Davydova, A., Danilin, N., Koroleva, L., Matveev, A., Bardasheva, A., Tikunova, N., Kupryushkin, M., Pyshnyi, D., Altman, S. & Venyaminova, A., 19 Jul 2019, In: Frontiers in Pharmacology. 10, 8 p., 813.

    Research output: Contribution to journal › Article › peer-review

ID: 3489985